--- title: "Cocrystal Pharma's CDI-988 Secures FDA Fast Track Designation To Prevent And Treat Norovirus" type: "News" locale: "en" url: "https://longbridge.com/en/news/281522861.md" description: "Cocrystal Pharma, Inc. (COCP) announced that the FDA has granted Fast Track designation to its drug CDI-988 for preventing and treating norovirus infection. The company views this as validation of its structure-based drug discovery technology. Co-CEO Sam Lee stated that CDI-988 shows potential in both preventing and treating the infection. COCP shares are trading at $1.03, up 0.98% on Nasdaq." datetime: "2026-04-02T12:20:54.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281522861.md) - [en](https://longbridge.com/en/news/281522861.md) - [zh-HK](https://longbridge.com/zh-HK/news/281522861.md) --- # Cocrystal Pharma's CDI-988 Secures FDA Fast Track Designation To Prevent And Treat Norovirus Add as your preferred news source on Google Add Now Cocrystal Pharma, Inc. (COCP), Thursday announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to CDI-988 for the treatment and prophylaxis of norovirus infection. The company believes that the designation further validates its unique structure-based drug discovery technology to design pan-viral antivirals that are effective new treatment options Sam Lee, co-CEO of Cocrystal Pharma, commented, "Based on compelling data generated to date, we believe that CDI-988 has the potential to both prevent and treat norovirus infection. In the pre-market hours, COCP is trading at $1.03, up 0.98 percent on the Nasdaq. For comments and feedback contact: editorial@rttnews.com Business News ### Related Stocks - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [COCP.US](https://longbridge.com/en/quote/COCP.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) ## Related News & Research - [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md) - [BioMarin's drug shows significant growth gains in children in late-stage trial](https://longbridge.com/en/news/287121584.md) - [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md) - [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md) - [](https://longbridge.com/en/news/286787081.md)